- Home
- IOVA vs EQX Comparison
IOVA vs EQX Comparison
Compare IOVA & EQX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- EQX
- Stock Information
- Founded
- IOVA 2007
- EQX 2007
- Country
- IOVA United States
- EQX Canada
- Employees
- IOVA N/A
- EQX N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- EQX Precious Metals
- Sector
- IOVA Health Care
- EQX Basic Materials
- Exchange
- IOVA Nasdaq
- EQX Nasdaq
- Market Cap
- IOVA 771.4M
- EQX 3.2B
- IPO Year
- IOVA N/A
- EQX N/A
- Fundamental
- Price
- IOVA $1.92
- EQX $6.30
- Analyst Decision
- IOVA Buy
- EQX
- Analyst Count
- IOVA 10
- EQX 0
- Target Price
- IOVA $12.22
- EQX N/A
- AVG Volume (30 Days)
- IOVA 10.7M
- EQX 15.8M
- Earning Date
- IOVA 08-07-2025
- EQX 08-13-2025
- Dividend Yield
- IOVA N/A
- EQX N/A
- EPS Growth
- IOVA N/A
- EQX N/A
- EPS
- IOVA N/A
- EQX 0.64
- Revenue
- IOVA $212,679,000.00
- EQX $1,696,526,000.00
- Revenue This Year
- IOVA $86.62
- EQX $40.61
- Revenue Next Year
- IOVA $69.95
- EQX $14.56
- P/E Ratio
- IOVA N/A
- EQX $9.91
- Revenue Growth
- IOVA 11070.12
- EQX 54.88
- 52 Week Low
- IOVA $1.64
- EQX $4.48
- 52 Week High
- IOVA $12.51
- EQX $7.45
- Technical
- Relative Strength Index (RSI)
- IOVA 54.54
- EQX 54.35
- Support Level
- IOVA $1.85
- EQX $5.70
- Resistance Level
- IOVA $2.02
- EQX $6.12
- Average True Range (ATR)
- IOVA 0.11
- EQX 0.19
- MACD
- IOVA 0.04
- EQX 0.06
- Stochastic Oscillator
- IOVA 97.44
- EQX 88.96
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About EQX Equinox Gold Corp.
Equinox Gold Corp is a mining company engaged in the operation, acquisition, exploration, and development of mineral properties, with a focus on gold. Equinox Gold has around seven operating gold mines and a clear plan to increase production by advancing the pipeline of growth projects. Geographically, the company operates in the United States, Mexico, and Brazil. The majority of its revenue is generated from Canada.